AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 9th, 2016 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
This Amendment No. 1 to Stock Purchase Agreement (this "Amendment') is dated as of March 7, 2016 by and between TNK Therapeutics, Inc., a Delaware corporation (the "Purchaser"), and Richard P. Junghans, M.D., Ph.D., as the Stockholders' Representative (the ''Representative").
Amendment No. 1 to MEmbership Interest PURCHASE AGREEMENTMembership Interest Purchase Agreement • November 9th, 2016 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
This Amendment No. 1 to Membership Interest Purchase Agreement (this “Amendment”) is dated as of March 7, 2016 by and between TNK Therapeutics, Inc., a Delaware corporation (the “Purchaser”), and Jaymin Patel, as the Members’ Representative (the “Representative”).
SORRENTO GATEWAY LEASELease • November 9th, 2016 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
This Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between HCP LIFE SCIENCE REIT, INC., a Maryland corporation (“Landlord”), and SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
